ZEISS Professional Education

Eduardo Besser, MD

Dr. Eduardo Besser, MD, demonstrates the power and versatility of the ZEISS VERACITY Surgical Planner and explains how it has streamlined his scheduling, IOL calculation, and data analysis processes.

Mark T. Dunbar, OD, FAAO, Jessica Steen, OD, FAAO, Dipl. ABO, Carolyn Majcher, OD, FAAO, FORS

Join Mark Dunbar, OD, FAAO, Jessica Steen, OD, FAAO, Dipl. ABO, and Carolyn Majcher, OD, FAAO during their session at Vision Expo West 2025, "Getting the Most Out of OCTA."

Katherine E. Talcott, MD, FASRS, Guarav K. Shah, MD, FASRS, Rishi P. Singh, MD, FASRS

Katherine E. Talcott, MD, FASRS, Rishi P. Singh, MD, FASRS, and Dr. Gaurav K. Shah, MD, FASRS share how this imaging can be employed to navigate difficult retinal cases.

Yasha Modi, MD MHS, Carolyn Majcher, OD, FAAO, FORS, Jessica Steen, OD, FAAO, Dipl. ABO

Timely intervention in retinal pathology management is key to preserving patients’ retinas and vision and requires early identification of biomarker changes. As Jessica Steen, OD, FAAO, Dipl. ABO, Carolyn Majcher, OD, FAAO, FORS, and Yasha Modi, MD, MHS, demonstrate, new technologies, such as ocular coherence tomography angiography (OCT-A), offer new insights into the varied ways in which retinal changes can present—including those obscured within the blind spots of other imaging modalities.

Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, Wesdon McCann, OD

Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, and Wesdon McCann, OD, share some case studies which highlight the varied ways that they have used new and traditional structural biomarkers to diagnose and manage glaucoma in their patients.